JPMorgan Chase & Co’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.27M | Buy |
1,958,433
+1,477,336
| +307% | +$1.71M | ﹤0.01% | 3252 |
|
|
2025
Q1 | $649K | Buy |
481,097
+283,846
| +144% | +$383K | ﹤0.01% | 3881 |
|
|
2024
Q4 | $2.6M | Buy |
197,251
+148,039
| +301% | +$1.95M | ﹤0.01% | 3226 |
|
|
2024
Q3 | $552K | Buy |
49,212
+22
| +0% | +$247 | ﹤0.01% | 3957 |
|
|
2024
Q2 | $529K | Sell |
49,190
-9,138
| -16% | -$98.2K | ﹤0.01% | 3835 |
|
|
2024
Q1 | $869K | Sell |
58,328
-27,265
| -32% | -$406K | ﹤0.01% | 3657 |
|
|
2023
Q4 | $1.55M | Buy |
85,593
+3,747
| +5% | +$67.9K | ﹤0.01% | 3284 |
|
|
2023
Q3 | $1.42M | Buy |
81,846
+8,649
| +12% | +$150K | ﹤0.01% | 3212 |
|
|
2023
Q2 | $1.33M | Buy |
73,197
+51,970
| +245% | +$942K | ﹤0.01% | 3259 |
|
|
2023
Q1 | $565K | Buy |
21,227
+6,268
| +42% | +$167K | ﹤0.01% | 3760 |
|
|
2022
Q4 | $290K | Sell |
14,959
-22,012
| -60% | -$427K | ﹤0.01% | 4035 |
|
|
2022
Q3 | $772K | Buy |
36,971
+35,385
| +2,231% | +$739K | ﹤0.01% | 3519 |
|
|
2022
Q2 | $13K | Sell |
1,586
-14,169
| -90% | -$116K | ﹤0.01% | 5138 |
|
|
2022
Q1 | $110K | Sell |
15,755
-38,081
| -71% | -$266K | ﹤0.01% | 4700 |
|
|
2021
Q4 | $727K | Buy |
53,836
+37,268
| +225% | +$503K | ﹤0.01% | 3862 |
|
|
2021
Q3 | $280K | Buy |
16,568
+3,448
| +26% | +$58.3K | ﹤0.01% | 4251 |
|
|
2021
Q2 | $382K | Sell |
13,120
-16,570
| -56% | -$482K | ﹤0.01% | 4146 |
|
|
2021
Q1 | $1.17M | Buy |
29,690
+25,014
| +535% | +$983K | ﹤0.01% | 3555 |
|
|
2020
Q4 | $106K | Buy |
4,676
+793
| +20% | +$18K | ﹤0.01% | 4296 |
|
|
2020
Q3 | $92K | Buy |
+3,883
| New | +$92K | ﹤0.01% | 4083 |
|